58Q-87130-23616

2 vaccinations 1 coded response 6 check-ins 0 free-text entries 0 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 101 / NY
Registered: 2023-05-01

Relationship: Self
Race: Asian
Ethnicity: Not Hispanic or Latino

Registered dependents

34F-86286-67383 Child or adolescent in my care · Female · 2023-05-15

BLB-96296-02579 Adult relative or friend · Female · 2023-05-16

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2023-03-01
Dose 1 — Pfizer-BioNTech
2023-05-01
Registered in v-safe
2023-05-01
Dose 2 — Pfizer-BioNTech
2023-05-01
Health check-in — day 0, dose 2
Feeling: Poor · None

Adult check-in
2023-05-02
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fever · Chills · Be unable to work or attend school

Adult check-in
2023-05-04
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Itching · Fever · Chills, Vomiting, Abdominal pain

Adult check-in
2023-05-15
Survey response — day 14, dose 2
MedDRA: No adverse event — Feeling: Fair · Be unable to work or attend school

MedDRA releases: 2024-11
2023-05-25
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2023-06-14
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2023-03-01	Pfizer-BioNTech	No
2	2023-05-01	Pfizer-BioNTech	No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	No adverse event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release